ASBP_OUT_1 [2025-03-20 10:56:12 -0400] 2240 Bytes | 609 tokens | Cum: 609 tkns (7.61% of 8k)
==========================================================================

We're scouting for winners today. Its 10:56:10 AM on Thursday March 20, 2025 ET (UTC-0400) and I'm looking at Aspire Biopharma (ASBP) up to 0.788 from 0.6599

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for Aspire Biopharma:

C1 - Today 08:30AM - Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice ('GMP') Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin
C2 - Mar-13-25 08:30AM - Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
C3 - Mar-11-25 08:00AM - An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation
C4 - Mar-03-25 07:30AM - Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement
C5 - Feb-25-25 07:30AM - Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
C6 - Feb-20-25 06:15PM - Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
C7 - Feb-20-25 06:15PM 07:30AM - Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
C8 - Feb-19-25 01:10PM - Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Aspire Biopharma (ASBP)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

ASBP_OUT_3 [2025-03-20 10:56:21 -0400] 525 Bytes | 139 tokens | Cum: 750 tkns (9.38% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice ('GMP') Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin**
Date: Today 08:30AM
Source: (ACCESSWIRE)
URL: https://www.accesswire.com/viewarticle.aspx?id=1002580

Error fetching article: 403 Client Error: Forbidden for url: https://www.accesswire.com/viewarticle.aspx?id=1002580

-- More? (MOR) or Next section? (NEX)

ASBP_OUT_5 [2025-03-20 10:56:22 -0400] 1014 Bytes | 284 tokens | Cum: 1149 tkns (14.36% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-20T12:44:04Z - Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed It...
A2 - 2025-03-20T12:49:57Z - Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed It...
A3 - 2025-03-20T12:41:04Z - Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed It...
A4 - 2025-03-13T12:46:40Z - Aspire Biopharma provides update on recently filed U.S. patent applications...
A5 - 2025-03-13T12:31:18Z - Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its ...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ASBP_OUT_7 [2025-03-20 10:56:23 -0400] 967 Bytes | 253 tokens | Cum: 1404 tkns (17.55% of 8k)
==========================================================================

Showing A1 (chunk 1 of 7): A1:
**Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (GMP) Clinical Batch of Pharmaceutical Grade Oral Mucosal By Investing.com**Date: 2025-03-20Source: {'uri': 'investing.com', 'dataType': 'news', 'title': 'Investing.com'}URL: https://www.investing.com/news/press-releases/aspire-biopharma-holdings-inc-contract-manufacturer-glatt-air-techniques-inc-has-completed-its-first-good-manufacturing-practice-gmp-clinical-batch-of-pharmaceutical-grade-oral-mucosal-93CH-3939333Subsequent phase involves completion of chemistry, manufacturing, and controls (CMC) testing for data to support FDA submission

Company expects to commence bioavailability study in April 2025

Aspire intends to request "fast track" approval on FDA application for its high dose aspirin product

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswi

-- More? (MOR) or Next section? (NEX)

ASBP_OUT_9 [2025-03-20 10:56:25 -0400] 267 Bytes | 67 tokens | Cum: 1473 tkns (18.41% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ASBP_OUT_11 [2025-03-20 10:56:26 -0400] 1140 Bytes | 315 tokens | Cum: 1790 tkns (22.38% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S1 - 2025-02-21 8-K Item 1.01. Entry into a Material Definitive Agrmt.

Securities Purchase Agrmt

On February 17, 2025, the Company entered into a Securities Purchase Agrmt (Securities Purchase Agrmt) with Cobra Alternative Capital Strategies, LLC, a sole member entity controlled ...

S2 - 2025-02-20 8-K Item 1.01. Entry into a Material Definitive Agrmt.

Equity Line of Credit

On February 13, 2025, the Company entered into a Purchase Agrmt (ELOC Agrmt) with Arena Business Solutions Global SPC II, Ltd. (Arena). Under the ELOC Agrmt, the Company has the right, bu...

S3 - 2024-12-26 8-K Item 1.01. Entry Into a Material Definitive Agrmt.

As previously disclosed, on August 26, 2024, PowerUp Acquisition Corp. (the Company) entered into an Agrmt and Plan of Merger by and among the Company, PowerUp Merger Sub II, Inc., a Delaware corporation and wholly owne...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

ASBP_OUT_13 [2025-03-20 10:56:28 -0400] 967 Bytes | 229 tokens | Cum: 2021 tkns (25.26% of 8k)
==========================================================================

Showing S2 (chunk 1 of 5): S2:
Item 1.01. Entry into a Material Definitive Agreement.

Equity Line of Credit

On February 13, 2025, the Company entered into a Purchase Agreement (ELOC Agreement) with Arena Business Solutions Global SPC II, Ltd. (Arena). Under the ELOC Agreement, the Company has the right, but not the obligation, to direct Arena to purchase up to $100,000,000 in shares of the Companys common stock (the ELOC Shares) upon satisfaction of certain terms and conditions contained in the ELOC Agreement, including, without limitation, an effective registration statement filed with the SEC registering the resale of ELOC Commitment Shares (as defined below) and additional shares to be sold to Arena from time to time under the ELOC Agreement. The term of the ELOC Agreement began on the date of execution and ends on the earlier of (i) the first day of the month following the 36-month anniversary of the execu

-- More? (MOR) or Next section? (NEX)

ASBP_OUT_15 [2025-03-20 10:56:44 -0400] 3407 Bytes | 865 tokens | Cum: 2888 tkns (36.10% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+----------------------+------------------------+----------------------+-------------------+
| Volume: 1,034,209 | SMA50: -89.29% | Market Cap: 35.89M | Option/Short: No / Yes | Sales past 5Y: 0.00% | Sales Surprise: - |
+---------------------+-----------------------+----------------------+------------------------+----------------------+-------------------+
| Avg Volume: 565.91K | SMA200: -92.40% | Shs Outstand: 46.01M | Short Float: 0.14% | Employees: 2 | EPS Surprise: - |
+---------------------+-----------------------+----------------------+------------------------+----------------------+-------------------+
| Rel Volume: 8.20 | Perf Week: 34.50% | Shs Float: 34.02M | Short Ratio: 0.08 | Debt/Eq: 59.33 | P/E: - |
+---------------------+-----------------------+----------------------+------------------------+----------------------+-------------------+
| RSI (14): 24.97 | Perf Month: -91.56% | Inst Own: 1.01% | Short Interest: 0.05M | Sales Y/Y TTM: - | Earnings: - |
+---------------------+-----------------------+----------------------+------------------------+----------------------+-------------------+
| ATR (14): 0.67 | Perf Quarter: -93.66% | Insider Own: 26.06% | Beta: 0.76 | ROE: -38.21% | |
+---------------------+-----------------------+----------------------+------------------------+----------------------+-------------------+
| SMA20: -28.18% | Index: - | Insider Trans: 0.00% | Sales Q/Q: - | ROI: -4161.59% | |
+---------------------+-----------------------+----------------------+------------------------+----------------------+-------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Now we've reached the end of the analysis.
You are now invited to make a summary analysis.
Please don't explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.
Please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]
Again, that is: 1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

[Company Financial Summary]
[Company Details]
Name: Aspire Biopharma Holdings, Inc. Common Stock
Market Cap: 30314156.250000004
Shares Outstanding: 45937500
Sector: PHARMACEUTICAL PREPARATIONS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.7899
Average Volume: 1177992.67
30-Day High: 6.16
30-Day Low: 0.58
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

ASBP_OUT_17 [2025-03-20 10:56:46 -0400] 561 Bytes | 131 tokens | Cum: 3331 tkns (41.64% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings & insider data
-> X3 <- Broader sector & market news
-> X4 <- General market sentiment & AI confidence levels
-> X5 <- AI's past analysis on similar companies
-> X6 <- More financial metrics
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

ASBP_IN_19 [2025-03-20 10:56:47 -0400] 126 Bytes | 29 tokens | Cum: 3367 tkns (42.09% of 8k)
==========================================================================

====================================
[2025-03-20 07:56:47] # Analysis Completed
Elapsed Time: 37.51 seconds